Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Swine
Flu Vaccine Delays Mean Targets Won't Be Met 10:42 AM 10/16/2009
Bloomberg
Swine flu vaccine production has been delayed which will have a
substantial impact on state schedules for inoculation as deaths rise above epidemic levels.
...
FDA
Sends Warnings To 17 Lasik Centers For Subpar Reporting 9:36 AM 10/16/2009
Wall Street Journal
The US FDA issued warning letters to 17 Lasik
vision-correction ambulatory surgical centers after inspections found inadequate recordkeeping.
...
Targacept
shares soar on promising depression drug data 9:17 AM 10/16/2009
Forbes
Targacept Inc reported positive data from a mid-stage trial of its
experimental drug TC-5214 with citalopram as an augmentation treatment for major depressive disorder.
...
Acetaminophen
given with vaccines can reduce their efficacy 6:16 AM 10/16/2009
Los Angeles Times
Fever is an essential part of the body's immune response. Giving
acetaminophen to infants following vaccination may reduce the effectiveness of the vaccines.
...
Cytos
anti-smoking vaccine flops 4:53 AM 10/16/2009
Forbes
Cytos Biotechnology's anti-smoking vaccine missed its main target in a mid-stage study.
The company will now probably miss out on a milestone payment by partner Novartis.
...
FDA
says don't buy swine flu drugs online 2:23 AM 10/16/2009
Los Angeles Times
The US FDA purchased several products online rarely receiving what was
advertised. One order for Tamiflu came in an unmarked envelope from India where most FDA approved generic drugs
are now manufactured.
...
Protalix's
Gaucher drug meets goal in late-stage study 6:20 AM 10/15/2009
Reuters
Protalix BioTherapeutics Inc said a late-stage trial of its drug Uplyso to
treat Gaucher disease met its main goal. If approved by the US FDA, the drug will compete with Genzyme Corp's
top-selling drug Cerezyme.
...
Roche
Raises Forecast as Tamiflu Orders Boost Sales 5:08 AM 10/15/2009
Wall Street Journal
Roche Holding AG raised its 2009 sales guidance for the second time
this year and reported better-than-expected third-quarter sales driven by orders for antiviral drug Tamiflu
(oseltamivir).
...
U.S.
FDA panel supports Acorda MS drug 5:22 PM 10/14/2009
Reuters
US health advisers backed Acorda Therapeutics Inc drug fampridine aimed at improving
walking ability of multiple sclerosis sufferers. The advisory panel said fampridine should not be used in people
with known seizure problems.
...
FDA warns P&G over vitamin C
in DayQuil and NyQuil 3:26 PM 10/14/2009
Reuters
The US FDA warned Procter & Gamble that its Vicks DayQuil and NyQuil products with
vitamin C have false and misleading labeling.
...
Amgen's
Bone Drug May Face Delays In FDA Decision 2:24 PM 10/14/2009
Wall Street Journal
Amgen Inc's osteoporosis drug denosumab is expected to be the most notable
launch in the biotech industry in years. Many expect the decision to be delayed.
...
US,
Canada regulators approve Pfizer-Wyeth deal 1:36 PM 10/14/2009
Forbes
Pfizer Inc's $68 billion purchase of Wyeth will close Thursday after antitrust
regulators in the US and Canada cleared the deal.
...
Ziopharm
cancer drug shows promise in mid-stage trial 9:05 AM 10/14/2009
Reuters
Ziopharm Oncology Inc's experimental cancer treatment Zymafos
(palifosfamide) met a key goal in a mid-stage trial for patients with unresectable or metastatic soft-tissue
sarcoma.
...
Phytopharm
shares soar on Parkinson's drug promise 8:25 AM 10/14/2009
Reuters
Phytopharm reported promising early test results with its Parkinson's
disease drug Cogane.
...
Mylan to sell generic of Pfizer antifungal drug 7:03 AM 10/14/2009
Reuters
Mylan Inc will have the right to sell a generic of Pfizer's Vfend
(voriconazole) antifungal drug in the first quarter of 2011 under a settlement and licensing agreement.
...
<- Day Earlier | Today's News
|
